Merit Medical Systems (MMSI) Expected to Announce Quarterly Earnings on Tuesday

Merit Medical Systems (NASDAQ:MMSI) is projected to post its Q4 2025 results after the market closes on Tuesday, February 24th. Analysts expect Merit Medical Systems to post earnings of $0.96 per share and revenue of $390.7730 million for the quarter. Individuals can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Tuesday, February 24, 2026 at 4:30 PM ET.

Merit Medical Systems Stock Up 0.5%

MMSI stock opened at $82.21 on Monday. The stock has a market cap of $4.87 billion, a P/E ratio of 42.16, a PEG ratio of 2.23 and a beta of 0.61. The company has a current ratio of 4.28, a quick ratio of 2.86 and a debt-to-equity ratio of 0.48. Merit Medical Systems has a twelve month low of $77.62 and a twelve month high of $107.27. The company’s 50 day moving average is $84.27 and its two-hundred day moving average is $85.03.

Insider Buying and Selling

In other news, Chairman Fred P. Lampropoulos sold 10,000 shares of the business’s stock in a transaction dated Tuesday, November 25th. The shares were sold at an average price of $88.04, for a total transaction of $880,400.00. Following the transaction, the chairman directly owned 1,019,955 shares in the company, valued at $89,796,838.20. The trade was a 0.97% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 3.70% of the company’s stock.

Institutional Investors Weigh In On Merit Medical Systems

A number of large investors have recently added to or reduced their stakes in MMSI. Wellington Management Group LLP raised its position in Merit Medical Systems by 377.7% during the third quarter. Wellington Management Group LLP now owns 1,240,509 shares of the medical instruments supplier’s stock worth $103,248,000 after acquiring an additional 980,823 shares during the last quarter. Iron Triangle Partners LP purchased a new position in shares of Merit Medical Systems during the 4th quarter worth approximately $33,992,000. Champlain Investment Partners LLC acquired a new position in shares of Merit Medical Systems during the 4th quarter worth approximately $32,359,000. Nomura Holdings Inc. raised its position in shares of Merit Medical Systems by 195.1% during the 3rd quarter. Nomura Holdings Inc. now owns 407,991 shares of the medical instruments supplier’s stock worth $33,957,000 after purchasing an additional 269,752 shares during the last quarter. Finally, Fuller & Thaler Asset Management Inc. lifted its stake in Merit Medical Systems by 12.7% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 2,077,796 shares of the medical instruments supplier’s stock valued at $183,137,000 after buying an additional 234,682 shares in the last quarter. 99.66% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages recently weighed in on MMSI. Wells Fargo & Company reduced their price target on shares of Merit Medical Systems from $103.00 to $95.00 and set an “overweight” rating for the company in a research report on Friday, November 14th. Barrington Research reissued an “outperform” rating and issued a $106.00 target price on shares of Merit Medical Systems in a research report on Friday, November 14th. Piper Sandler dropped their price target on Merit Medical Systems from $113.00 to $106.00 and set an “overweight” rating on the stock in a research note on Wednesday. Weiss Ratings reiterated a “hold (c)” rating on shares of Merit Medical Systems in a research note on Monday, December 29th. Finally, Needham & Company LLC restated a “buy” rating and set a $108.00 target price on shares of Merit Medical Systems in a research report on Friday, January 9th. Nine equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Merit Medical Systems currently has an average rating of “Moderate Buy” and an average price target of $105.67.

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.